Toyota|$17.64 (¥2,817)-3.06%▼ (in JPY terms)
Sony|$22.38 (¥3,574)+0.90%▲ (in JPY terms)
SoftBank|$55.47 (¥8,857)+3.70%▲ (in JPY terms)
MUFG|$18.81 (¥3,003)-0.66%▼ (in JPY terms)
Keyence|$492.49 (¥78,640)-1.97%▼ (in JPY terms)
Nintendo|$45.81 (¥7,315)+2.12%▲ (in JPY terms)
NTT|$0.92 (¥147)-0.68%▼ (in JPY terms)
Takeda|$30.13 (¥4,811)-1.43%▼ (in JPY terms)
Tokyo Electron|$332.92 (¥53,160)+0.19%▲ (in JPY terms)
Recruit|$69.17 (¥11,045)+1.33%▲ (in JPY terms)
ITOCHU|$11.59 (¥1,850)-1.57%▼ (in JPY terms)
Honda|$8.62 (¥1,377)-1.78%▼ (in JPY terms)
Shin-Etsu|$46.71 (¥7,459)-4.29%▼ (in JPY terms)
Tokio Marine|$44.51 (¥7,107)-0.01%▼ (in JPY terms)
Fast Retailing|$498.94 (¥79,670)-1.04%▼ (in JPY terms)
Toyota|$17.64 (¥2,817)-3.06%▼ (in JPY terms)
Sony|$22.38 (¥3,574)+0.90%▲ (in JPY terms)
SoftBank|$55.47 (¥8,857)+3.70%▲ (in JPY terms)
MUFG|$18.81 (¥3,003)-0.66%▼ (in JPY terms)
Keyence|$492.49 (¥78,640)-1.97%▼ (in JPY terms)
Nintendo|$45.81 (¥7,315)+2.12%▲ (in JPY terms)
NTT|$0.92 (¥147)-0.68%▼ (in JPY terms)
Takeda|$30.13 (¥4,811)-1.43%▼ (in JPY terms)
Tokyo Electron|$332.92 (¥53,160)+0.19%▲ (in JPY terms)
Recruit|$69.17 (¥11,045)+1.33%▲ (in JPY terms)
ITOCHU|$11.59 (¥1,850)-1.57%▼ (in JPY terms)
Honda|$8.62 (¥1,377)-1.78%▼ (in JPY terms)
Shin-Etsu|$46.71 (¥7,459)-4.29%▼ (in JPY terms)
Tokio Marine|$44.51 (¥7,107)-0.01%▼ (in JPY terms)
Fast Retailing|$498.94 (¥79,670)-1.04%▼ (in JPY terms)

2026-05-08 MITSUI & CO.,LTD. “We have established a joint venture company, "Ceva Bussan Animal Health," for our animal pharmaceutical business in Japan — further strengthening our strategic collaboration with the French animal health company Ceva Santé Animale —.”

by

2026-05-08 MITSUI & CO.,LTD. “We have established a joint venture company, "Ceva Bussan Animal Health," for our animal pharmaceutical business in Japan — further strengthening our strategic collaboration with the French animal health company Ceva Santé Animale —.”

AI-Generated Summary

Mitsui & Co. has strengthened its position in Japan’s animal pharmaceutical market through a joint venture with French company Ceva Santé Animale, signaling management’s confidence in the growth potential of the animal health sector and its ability to leverage international partnerships. This strategic collaboration allows Mitsui to expand its portfolio in a specialized healthcare segment while sharing risks and expertise with an established global player in animal pharmaceuticals.

This summary is AI-generated based on the release title and may not reflect the full content of the original document.

Tags: JP3893600001MITSUI & CO.,LTD.

コメントする

Contact